Literature DB >> 11779189

Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy.

Kenneth J McDonald1, Angus J M Cameron, Janet M Allen, Alan G Jardine.   

Abstract

IgA nephropathy is characterized by the deposition of IgA immune complexes in the glomerular mesangium, but the mechanisms responsible for this are not well understood. Human mesangial cells (HMCs) can bind IgA but do not express known IgA receptors. We show here that primary HMCs express mRNA for a novel receptor, the Fc alpha/mu receptor (Fcalpha/muR), and that receptor expression is upregulated by IL-1. We also detected mRNA for a novel receptor variant in HMCs that may encode a soluble form of the receptor. Fcalpha/muR was expressed in a heterologous system which showed that the receptor was approximately 58 kDa in weight and was only minimally N-glycosylated. As predicted from the characteristics of the murine homologue, the expressed human Fcalpha/muR was able to bind IgA and IgM, but not IgG. These results suggest that Fcalpha/muR may be the receptor responsible for mesangial IgA deposition in IgA nephropathy. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779189     DOI: 10.1006/bbrc.2001.6218

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

2.  Environmental Enrichment Induces Pericyte and IgA-Dependent Wound Repair and Lifespan Extension in a Colon Tumor Model.

Authors:  Benjamin D Bice; Megan R Stephens; Stephanie J Georges; Ashlee R Venancio; Peter C Bermant; Annika V Warncke; Kajsa E Affolter; Julio R Hidalgo; Melinda L Angus-Hill
Journal:  Cell Rep       Date:  2017-04-25       Impact factor: 9.423

Review 3.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

4.  Molecular and functional characteristics of the Fcalpha/muR, a novel Fc receptor for IgM and IgA.

Authors:  Akira Shibuya; Shin-Ichiro Honda
Journal:  Springer Semin Immunopathol       Date:  2006-10-24

Review 5.  New insights into the pathogenesis of IgA nephropathy.

Authors:  Jürgen Floege; Ivan C Moura; Mohamed R Daha
Journal:  Semin Immunopathol       Date:  2014-01-18       Impact factor: 9.623

6.  Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules.

Authors:  Y-H Gao; L-X Xu; J-J Zhang; Y Zhang; M-H Zhao; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2007-03-26       Impact factor: 4.330

7.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

8.  Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schonlein purpura.

Authors:  Roland Schmitt; Fredric Carlsson; Matthias Mörgelin; Ramesh Tati; Gunnar Lindahl; Diana Karpman
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

9.  Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor.

Authors:  Kaoru Kikuno; Dong-Won Kang; Kazuki Tahara; Ikuko Torii; Homare M Kubagawa; Kang Jey Ho; Lucie Baudino; Naoto Nishizaki; Akira Shibuya; Hiromi Kubagawa
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

Review 10.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.